TY - JOUR
T1 - Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A(4) hydrolase
AU - Kirkland, Thomas A.
AU - Adler, Marc
AU - Bauman, John G.
AU - Chen, Ming
AU - Haeggstrom, Jesper Z.
AU - King, Beverly
AU - Kochanny, Monica J.
AU - Liang, Amy M.
AU - Mendoza, Lisa
AU - Phillips, Gary B.
AU - Thunnissen, Marjolein
AU - Trinh, Lan
AU - Whitlow, Marc
AU - Ye, Bin
AU - Ye, Hong
AU - Parkinson, John
AU - Guilford, William J.
PY - 2008
Y1 - 2008
N2 - Leukotriene B-4 (LTB4) is a potent pro-inflammatory mediator that has been implicated in the pathogenesis of multiple diseases, including psoriasis, inflammatory bowel disease, multiple sclerosis and asthma. As a method to decrease the level of LTB4 and possibly identify novel treatments, inhibitors of the LTB4 biosynthetic enzyme, leukotriene A(4) hydrolase (LTA(4)-h), have been explored. Here we describe the discovery of a potent inhibitor of LTA(4)-h, arylamide of glutamic acid 4f, starting from the corresponding glycinamide 2. Analogs of 4f are then described, focusing on compounds that are both active and stable in whole blood. This effort culminated in the identification of amino alcohol 12a and amino ester 6b which meet these criteria.
AB - Leukotriene B-4 (LTB4) is a potent pro-inflammatory mediator that has been implicated in the pathogenesis of multiple diseases, including psoriasis, inflammatory bowel disease, multiple sclerosis and asthma. As a method to decrease the level of LTB4 and possibly identify novel treatments, inhibitors of the LTB4 biosynthetic enzyme, leukotriene A(4) hydrolase (LTA(4)-h), have been explored. Here we describe the discovery of a potent inhibitor of LTA(4)-h, arylamide of glutamic acid 4f, starting from the corresponding glycinamide 2. Analogs of 4f are then described, focusing on compounds that are both active and stable in whole blood. This effort culminated in the identification of amino alcohol 12a and amino ester 6b which meet these criteria.
KW - leukotriene A4
KW - inhibitor
KW - crystal structure
U2 - 10.1016/j.bmc.2008.03.042
DO - 10.1016/j.bmc.2008.03.042
M3 - Article
C2 - 18394906
SN - 0968-0896
VL - 16
SP - 4963
EP - 4983
JO - Bioorganic & Medicinal Chemistry
JF - Bioorganic & Medicinal Chemistry
IS - 9
ER -